Pay in 4 interest-free payments of $7.24 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
AOD 9604 is a synthetic peptide fragment derived from human growth hormone, while retatrutide is an investigational triple incretin receptor agonist currently in Phase 3 trials
Researchers using this tool must verify all values against their vials certificate of analysis and labelling
Combining with AOD-9604 provides dual pathway activationgrowth hormone release via tesamorelin plus direct lipolytic action from AOD-9604though this requires careful physician oversight
It is dosed at 200 mcg to 500 mcg daily, subcutaneously typically at night to align with the bodys natural GH pulse
It is not for human or veterinary consumption, diagnostic, therapeutic, or any other non-research use
US$ 27.16
US$ 26.79
US$ 21.35
US$ 23.59
US$ 23.43
